-- 根据FactSet调查的分析师报告,Tvardi Therapeutics (TVRD) 的平均评级为“增持”,平均目标价为8.17美元。 (报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们:https://www..com/contact-us)
Related Articles
ACT Energy Technologies Repays US$20.0 Million of Exchangeable Subordinated Promissory Note
ACT Energy Technologies (ACX.TO) repaid in full the outstanding exchangeable subordinated promissory note, issued in connection with its acquisition of Rime Downhole Technologies, on July 11, 2023, it said on Monday.The company repaid US$20.0 million of the note, plus accrued interest. The early repayment of the note was funded using the available US$20.0 million term facility provided by the company's syndicate of lenders, it said.Shares of the company closed up 4.1% to $6.68 on Friday on the Toronto Stock Exchange.
Canada to Announce Creation of A Sovereign Wealth Fund This Morning, says Scotiabank
The Canadian federal government, led by Prime Minister Mark Carney, will announce a new sovereign wealth fund in a press conference at 9:15 a.m. ET on Monday in Ottawa, while Finance Minister Francois-Philippe Champagne will follow that up with a press conference at 10 a.m. ET in Montreal, says Scotiabank in its Monday morning note.The announcements around the fund will come ahead of Tuesday's Spring economic update from the federal government and, further down the road, ahead of a September investment conference that the Carney administration is planning, aimed at attracting global investment to Canada, notes Scotiabank."The devil will be very much in the details", says the bank of the new fund.One immediate observation from Scotiabank is that usually countries with sovereign wealth funds are net savers. Canada isn't.
Jefferies Adjusts Price Target on EQT to $77 From $76, Maintains Buy Rating
EQT (EQT) has an average rating of overweight and mean price target of $70.76, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)